ADAT1 Human

Adenosine Deaminase tRNA-Specific 1 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Enzymatic Function and Substrate Specificity

ADAT1 exclusively targets adenosine at position 37 in the anticodon loop of tRNA-Ala, a conserved modification across eukaryotes . Key findings include:

  • Mechanism: Hydrolytic deamination of A37, forming inosine, which may undergo further methylation to N1-methylinosine (m1I37) .

  • Substrate Requirements: Requires the full-length tRNA-Ala structure; isolated anticodon stem-loops are insufficient .

  • Specificity: Does not edit double-stranded RNA or pre-mRNA substrates of other ADAR proteins .

  • Efficiency: Higher activity on tRNA-Ala from humans and Bombyx mori compared to yeast .

Genomic Organization and Evolutionary Conservation

  • Gene Structure: The ADAT1 gene spans ~30 kb, with nine exons in mice and humans .

  • Homology: 87.5% protein identity between human and mouse ADAT1 .

  • Evolution: Functional homologs exist in Drosophila melanogaster and yeast (Tad1p), though yeast lacks the 90-amino acid insert found in human ADAT1 .

Expression Profile and Tissue Distribution

ADAT1 is ubiquitously expressed, with transcript levels highest in the heart, brain, and pancreas . Northern blot analyses detect two transcripts (5.0 kb and 6.5 kb), likely due to extended 3'-untranslated regions .

TissueExpression LevelSource
HeartHigh
BrainHigh
PancreasHigh
LungLow
Skeletal MuscleLow

Research Tools and Reagents

  • Recombinant Protein: Available as a non-glycosylated, E. coli-derived product (ENZ-307) .

  • ELISA Kits: Detect native ADAT1 in biological samples (e.g., MBS7209441) .

  • Antibodies: Rabbit polyclonal antibodies (e.g., ab122662) validated for WB, IHC-P, and ICC/IF .

Functional Associations and Pathological Implications

ADAT1 is linked to:

  • RNA Processing: Co-expressed with tRNA synthetases and other RNA-modifying enzymes .

  • Disease Associations: GWAS data implicate ADAT1 in neurological and metabolic disorders, though direct mechanisms remain under investigation .

Product Specs

Introduction
The ADAR (adenosine deaminase acting on RNA) gene family includes this particular gene. Proteins produced by these genes use site-specific adenosine modification to contribute to the pre-mRNA editing of nuclear transcripts. The deamination of adenosine 37 to inosine in eukaryotic tRNA is carried out by tRNA-specific adenosine deaminase 1, which is encoded by this gene.
Description
Recombinant Human Adenosine Deaminase tRNA-Specific 1 is a non-glycosylated polypeptide chain with a molecular weight of 57.7 kDa that is generated in E. Coli. It has the amino acids 1-502. A T7 tag is present at the N-terminus of ADAT-1. Using exclusive chromatographic methods, ADAT1 is purified.
Physical Appearance
A clear, sterile filtered solution.
Formulation
Adenosine Deaminase tRNA-Specific-1 is present at a concentration of 0.1 mg/ml in a solution containing 10 mM Tris (pH 8.0), 0.1% Triton X-100, and 0.002% NaN3.
Stability
If the entire vial will be used within 2-4 weeks, store at 4°C. For longer periods of time, store frozen at -20°C. It is advised to add a carrier protein (0.1% HSA or BSA) for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
SDS-PAGE analysis revealed a purity greater than 95.0%.
Synonyms
tRNA-specific adenosine deaminase 1, hADAT1, tRNA-specific adenosine- 37 deaminase, ADAT1, ADAT-1.
Source
Escherichia Coli.

Q&A

What is ADAT1 and what is its primary function in cellular biology?

ADAT1 (Adenosine Deaminase tRNA-Specific 1) is a member of the ADAR (adenosine deaminase acting on RNA) family. Its primary function is the site-specific deamination of adenosine 37 to inosine in eukaryotic tRNA(Ala) . Unlike other ADAR family members that modify various RNA substrates, ADAT1 displays remarkable specificity for tRNA(Ala). This modification represents the first step of the unique A(37) to m(1)I(37) modification pathway in eukaryotic tRNA(Ala) .

The human ADAT1 protein consists of 502 amino acids with a molecular mass of approximately 57.7 kDa . It is expressed ubiquitously in human tissues and is encoded by a single gene . This enzyme is the functional homologue of the yeast protein Tad1p, indicating evolutionary conservation of this modification mechanism .

How does ADAT1 relate structurally and functionally to other members of the ADAR family?

While ADAT1 belongs to the ADAR family, it has distinct substrate specificity compared to other family members:

This specialized function separates ADAT1 from its ADAR relatives, making it a unique enzyme within this family focused specifically on tRNA modification rather than broader RNA editing activities.

What expression systems and purification methods are optimal for producing functional ADAT1?

For optimal expression and purification of human ADAT1:

Expression Systems:
Escherichia coli has been successfully used as an expression system for producing recombinant human ADAT1 . The recombinant protein is typically expressed as a non-glycosylated polypeptide chain containing amino acids 1-502 .

Purification Methods:
The most effective purification approach involves:

  • Expression with an affinity tag (such as T7 tag at N-terminus)

  • Purification using proprietary chromatographic techniques

  • Quality assessment by SDS-PAGE to ensure >95% purity

Formulation and Storage:
The purified protein is typically formulated in a buffer containing:

ComponentConcentration
ADAT1 protein0.1 mg/ml
Tris buffer10 mM, pH 8.0
Triton X-1000.1%
Sodium azide0.002%

For storage, the enzyme should be kept at 4°C if used within 2-4 weeks, or frozen at -20°C for longer periods . Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage, and multiple freeze-thaw cycles should be avoided .

What assays can effectively measure ADAT1 enzymatic activity and specificity?

Several approaches can be used to assess ADAT1 activity:

Substrate Preparation:
Use purified tRNA(Ala) from either:

  • In vitro transcription of tRNA(Ala) genes

  • Isolation from cellular sources (preferably higher eukaryotes for optimal activity)

Activity Assays:

  • Direct deamination detection: Monitor the conversion of adenosine to inosine at position 37 in tRNA(Ala) using techniques like thin-layer chromatography or mass spectrometry.

  • Comparative substrate analysis: Test ADAT1 activity on tRNA(Ala) from different species, as human ADAT1 shows higher efficiency with substrates from higher eukaryotes compared to lower eukaryotes .

Important Considerations:

  • The complete tRNA structure is necessary for ADAT1 activity; the anticodon stem-loop alone is not a functional substrate .

  • Negative controls should include testing activity on double-stranded RNA or pre-mRNAs that serve as substrates for ADAR1 or ADAR2, as ADAT1 should not modify these substrates .

How does ADAT1 achieve its remarkable substrate specificity for tRNA(Ala)?

ADAT1's specificity for tRNA(Ala) involves multiple recognition elements:

  • Structural requirements: Research demonstrates that the anticodon stem-loop of tRNA(Ala) alone is insufficient for recognition by ADAT1 . This indicates that tertiary structural elements or distant sequence motifs in the complete tRNA are essential for substrate recognition.

  • Species-dependent activity: Human ADAT1 deaminates tRNA(Ala) from higher eukaryotes efficiently but shows lower efficiency with substrates from lower eukaryotes . This suggests evolutionary adaptations in the enzyme-substrate recognition system.

  • Position-specific modification: ADAT1 specifically targets adenosine at position 37 in the anticodon loop, adjacent to the anticodon itself (positions 34-36) . This position is critical for maintaining proper tRNA function during translation.

Understanding this specificity requires investigation of both enzyme structural elements and tRNA features that facilitate this highly selective interaction. Mutagenesis studies of both the enzyme and substrate would help identify key recognition determinants.

What is the evolutionary significance of A37 to I37 modification in tRNA(Ala)?

The evolutionary significance of this modification is profound:

  • Phylogenetic conservation: The A37 to I37 modification in tRNA(Ala) is conserved from yeast to humans, indicating fundamental importance in cellular function . Both human and mouse ADAT1 are expressed from single-copy genes with similar organization .

  • Mouse-human homology: Mouse ADAT1 shares 81% nucleotide homology and 87.5% protein homology with human ADAT1, further demonstrating evolutionary conservation . The mouse enzyme is also active specifically and with high efficiency on human tRNA(Ala) in vitro .

  • Functional importance: The modification likely plays crucial roles in:

    • Stabilizing codon-anticodon interactions

    • Ensuring translational fidelity

    • Preventing frameshifting during protein synthesis

  • Multi-step modification: In eukaryotes, this represents the first step of a two-step modification, with I37 further modified to m(1)I(37) . This sequential modification pattern suggests coordinated evolution of RNA modification pathways.

What genomic analysis techniques are valuable for studying ADAT1 across species?

For comparative genomic analysis of ADAT1:

  • Gene structure analysis:

    • In mouse, the ADAT1 coding region spans nine exons covering approximately 30kb of genomic DNA .

    • Comparative analysis with human ADAT1 genomic organization can reveal conserved regulatory elements.

  • Homology assessment:

    • Sequence alignment tools to compare ADAT1 across species

    • Phylogenetic analysis to understand evolutionary relationships

    • Structural prediction based on sequence conservation

  • Expression analysis:

    • Evaluating tissue-specific expression patterns

    • Identifying potential splice variants or isoforms

  • Promoter analysis:

    • ADAR1 (related to ADAT1) has two transcription start sites and two promoters, leading to production of a shorter isoform that lacks the first 296 residues of the long form . Similar analysis of ADAT1 promoter structure could reveal regulatory mechanisms.

How can researchers design experiments to elucidate the structural basis of ADAT1-tRNA interaction?

To investigate ADAT1-tRNA structural interactions:

  • Mutagenesis approaches:

    • Systematic mutation of conserved residues in ADAT1 to identify those critical for tRNA binding and catalysis

    • Creation of chimeric constructs between ADAT1 and other ADAR family members to map substrate specificity domains

  • tRNA variant studies:

    • Generation of tRNA(Ala) variants with specific structural changes

    • Transplantation of tRNA(Ala) structural elements into non-substrate tRNAs to identify recognition determinants

  • Biophysical interaction analysis:

    • Surface plasmon resonance or isothermal titration calorimetry to measure binding kinetics

    • Crosslinking studies to identify contact points between ADAT1 and tRNA

  • Structural biology methods:

    • X-ray crystallography or cryo-EM of ADAT1-tRNA complexes

    • NMR studies of specific domains and their interaction with RNA elements

These approaches would generate a comprehensive understanding of the molecular basis for ADAT1's remarkable substrate specificity.

How should researchers approach contradictory results in ADAT1 activity assays?

When facing contradictory results in ADAT1 studies:

  • Experimental variables assessment:

    • Review buffer conditions: optimal activity requires appropriate pH, salt concentration, and possible cofactors

    • Verify enzyme purity (>95% as determined by SDS-PAGE is standard)

    • Check storage conditions and enzyme batch variation

  • Substrate integrity verification:

    • Ensure tRNA substrates maintain proper folding

    • Consider differences between in vitro transcribed versus native tRNAs

    • Remember that the anticodon stem-loop alone is not a substrate for ADAT1

  • Activity detection methods:

    • Employ multiple independent methods to verify results

    • Include appropriate positive and negative controls

    • Consider time-course experiments to capture reaction kinetics

  • Comparative analysis:

    • Test ADAT1 activity on tRNA(Ala) from different species as validation

    • Use relative activity measurements to normalize between experiments

What are key considerations when designing structure-function studies of ADAT1?

For effective structure-function studies:

  • Domain organization analysis:

    • The catalytic domain of ADAT1 is closely related to other ADAR proteins

    • Identify conserved motifs across the ADAR family to target for mutagenesis

  • Evolutionary perspective:

    • Leverage the strong homology between mouse and human ADAT1 (87.5% protein homology)

    • Consider the more distant relationship with the Drosophila melanogaster homolog (50% similarity, 32% identity)

  • Substrate specificity determinants:

    • Investigate why ADAT1 doesn't modify adenosines in double-stranded RNA or pre-mRNAs unlike other ADARs

    • Examine recognition elements beyond the anticodon loop that contribute to specificity

  • Methodological integration:

    • Combine biochemical assays with structural studies

    • Correlate activity measurements with binding affinity determination

    • Consider computational modeling to guide experimental design

By systematically addressing these aspects, researchers can develop a comprehensive understanding of ADAT1 structure-function relationships, contributing to broader knowledge of RNA modification enzymes.

Product Science Overview

Function and Mechanism

ADAT1 specifically deaminates adenosine at position 37 to inosine in eukaryotic tRNA, particularly in tRNA-Ala . This modification is essential for the proper functioning of tRNA, as inosine at position 37 is critical for maintaining the correct structure and function of the tRNA molecule . The enzyme’s activity involves site-specific adenosine modification, which is a key process in the pre-mRNA editing of nuclear transcripts .

Gene Structure and Expression

The ADAT1 gene is located on chromosome 16q23.1 and consists of 9 exons . The gene is highly conserved across species, indicating its essential role in cellular processes. ADAT1 transcripts are found in various human tissues, with the highest expression levels observed in the heart, brain, and pancreas .

Evolutionary Significance

The ADAT1 protein shares significant sequence similarity with the yeast protein Tad1p, which also deaminates adenosine to inosine in tRNA . This evolutionary conservation suggests that the function of ADAT1 is critical across different organisms, highlighting its importance in maintaining the integrity of the genetic code during protein synthesis.

Clinical Relevance

Mutations or dysregulation of the ADAT1 gene have been associated with several diseases, including prostate cancer and developmental and epileptic encephalopathy . Understanding the function and regulation of ADAT1 can provide insights into the molecular mechanisms underlying these conditions and potentially lead to the development of targeted therapies.

Research and Applications

Recombinant human ADAT1 is used in various research applications to study RNA editing and its implications in health and disease. By using recombinant proteins, researchers can investigate the enzyme’s activity, substrate specificity, and potential inhibitors, which can contribute to the development of novel therapeutic strategies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.